Solid Malignancies clinical trials at UC Cancer
1 research study open to eligible people
Showing trials for
Safety and Efficacy Study of CFI-402411 in Subjects With Advanced Solid Malignancies
open to eligible people ages 18 years and up
The purpose of this study is to test the safety of an investigational drug called CFI-402411 alone and in combination with pembrolizumab and to study its effects in patients with advanced solid tumors who have progressed following previous therapies.
at UCSD